Literature DB >> 32081609

Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Qianru Huang1, Xu Liu1, Yujia Zhang1, Jingyao Huang1, Dan Li2, Bin Li3.   

Abstract

Regulatory T (Treg) cells, a subtype of immunosuppressive CD4+ T cells, are vital for maintaining immune homeostasis in healthy people. Forkhead box protein P3 (FOXP3), a member of the forkhead-winged-helix family, is the pivotal transcriptional factor of Treg cells. The expression, post-translational modifications, and protein complex of FOXP3 present a great impact on the functional stability and immune plasticity of Treg cells in vivo. In particular, the mutation of FOXP3 can result in immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, which is a rare genetic disease mostly diagnosed in early childhood and can soon be fatal. IPEX syndrome is related to several manifestations, including dermatitis, enteropathy, type 1 diabetes, thyroiditis, and so on. Here, we summarize some recent findings on FOXP3 regulation and Treg cell function. We also review the current knowledge about the underlying mechanism of FOXP3 mutant-induced IPEX syndrome and some latest clinical prospects. At last, this review offers a novel insight into the role played by the FOXP3 complex in potential therapeutic applications in IPEX syndrome.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  FOXP3; IPEX syndrome; Immune cell therapy; Post-translational modification; Regulatory T cell; Transcriptional complex ensemble

Mesh:

Substances:

Year:  2020        PMID: 32081609     DOI: 10.1016/j.jgg.2019.11.011

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  4 in total

1.  Immune dysregulation, polyendocrinopathy and enteropathy, X-linked (IPEX) syndrome due to a mutation in FOXP3, modified by a pathogenic variant in SON (SON DNA-binding protein).

Authors:  Ranjit I Kylat; Kelly Stanley; Sarah Simon; Robert P Erickson
Journal:  J Appl Genet       Date:  2022-09-30       Impact factor: 2.653

2.  Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3+ Tregs.

Authors:  Xin Chen; M Cecilia Berin; Virginia L Gillespie; Hugh A Sampson; David Dunkin
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 3.  IPEX Syndrome: Genetics and Treatment Options.

Authors:  Iwona Ben-Skowronek
Journal:  Genes (Basel)       Date:  2021-02-24       Impact factor: 4.096

4.  Immune Monitoring of Patients With Primary Immune Regulation Disorders Unravels Higher Frequencies of Follicular T Cells With Different Profiles That Associate With Alterations in B Cell Subsets.

Authors:  María Soledad Caldirola; María Paula Martínez; Liliana Bezrodnik; Norberto Walter Zwirner; María Isabel Gaillard
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.